Valuation Ipca Laboratories Limited Bombay S.E.

Stocks

Market Closed - Bombay S.E. Other stock markets 06:00:53 2026-06-12 EDT			5-day change	1st Jan Change
1,585.80 ^INR	-1.69%		-3.48%	+11.36%

06-01	Ipca Laboratories Limited, Q4 2026 Earnings Call, Jun 01, 2026
05-29	Ipca Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	241,495	270,385	205,589	313,934	381,038	401,614	-	-
Change	-	11.96%	-23.96%	52.7%	21.38%	5.4%	-	-
Enterprise Value (EV) ¹	239,835	275,070	201,870	325,349	391,231	408,673	384,445	374,727
Change	-	14.69%	-26.61%	61.17%	20.25%	4.46%	-3.06%	-2.53%
P/E Ratio	21.1x	30.6x	43.6x	57.4x	51.6x	35.6x	28.8x	24.2x
PBR	5.14x	4.92x	2.58x	4.96x	5.48x	5.04x	4.28x	3.7x
PEG	-	-1.4x	-0.9x	3.6x	1.5x	0.7x	1.2x	1.3x
Capitalization / Revenue	4.46x	4.64x	3.29x	4.07x	4.26x	4.21x	3.73x	3.34x
EV / Revenue	4.43x	4.72x	3.23x	4.22x	4.38x	4.24x	3.57x	3.12x
EV / EBITDA	15.5x	21x	21.8x	24.6x	22.7x	20.7x	16.3x	13.7x
EV / EBIT	18x	25.6x	30.3x	33.8x	29.5x	26.2x	20.3x	17x
EV / FCF	32.9x	72.9x	64.8x	60.9x	71.7x	83.5x	40.5x	34.1x
FCF Yield	3.04%	1.37%	1.54%	1.64%	1.4%	1.2%	2.47%	2.93%
Dividend per Share ²	4	8	4	4	2	6	5.792	6.258
Rate of return	0.42%	0.75%	0.49%	0.32%	0.13%	0.37%	0.37%	0.4%
EPS ²	45.06	34.85	18.58	21.57	29.08	44.98	55.01	65.51
Distribution rate	8.88%	23%	21.5%	18.5%	6.88%	13.3%	10.5%	9.55%
Net sales ¹	54,200	58,298	62,443	77,050	89,396	96,463	107,715	120,158
EBITDA ¹	15,444	13,073	9,268	13,212	17,261	19,786	23,587	27,340
EBIT ¹	13,352	10,748	6,652	9,639	13,283	15,604	18,929	22,039
Net income ¹	11,400	8,841	4,713	5,474	7,377	11,411	14,037	16,700
Net Debt ¹	-1,660	4,685	-3,720	11,415	10,193	2,442	-17,169	-26,887
Reference price ²	951.88	1,065.75	810.35	1,237.40	1,501.90	1,583.00	1,583.00	1,583.00
Nbr of stocks (in thousands)	253,704	253,704	253,704	253,704	253,704	253,704	-	-
Announcement Date	5/28/21	5/24/22	5/29/23	5/29/24	5/29/25	5/29/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.15x	12.05x	24.81x	0.6%	1,010B
JOHNSON & JOHNSON	25.74x	5.93x	16.13x	2.22%	580B
ABBVIE INC.	27.88x	6.79x	13.86x	3.01%	402B
ROCHE HOLDING AG	17.71x	4.37x	10.73x	3.04%	330B
NOVARTIS AG	21.24x	5.49x	13.32x	2.92%	281B
ASTRAZENECA PLC	22.78x	4.74x	13.47x	1.85%	280B
NOVO NORDISK A/S	12.7x	4.76x	9.73x	3.95%	197B
AMGEN INC.	23.09x	6.16x	10.76x	2.84%	192B
GILEAD SCIENCES, INC.	-45x	5.43x	29.95x	2.58%	156B
Average	15.48x	6.19x	15.86x	2.56%	380.99B
Weighted average by Cap.	22.68x	7.47x	17.41x	2.09%